Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Sep 22:2014:bcr2014206034.
doi: 10.1136/bcr-2014-206034.

Pulmonary actinomycosis and Hodgkin's disease: when FDG-PET may be misleading

C Weisshaupt  1 , F Hitz  1 , W C Albrich  2 , A Omlin  1
Affiliations
Case Reports

Pulmonary actinomycosis and Hodgkin's disease: when FDG-PET may be misleading

C Weisshaupt et al. BMJ Case Rep. .

Abstract

We present a patient with advanced Hodgkin's disease treated with escalated BEACOPP chemotherapy. The result from the interim fluorodeoxyglucose positron emission tomography with CT (PET-CT) after two cycles of chemotherapy is crucial for treatment guidance for the clinical trial HD18 from the German Hodgkin Study Group. An increase in size and standard uptake value (SUV) of a pulmonary lesion suggesting refractory Hodgkin's disease was documented. Since all other manifestations of the lymphoma responded well to the treatment, the discordant behaviour was suspicious for another reason for this progressive pulmonary lesion. Bronchoscopy revealed Actinomyces species in cultures from bronchial washings. Specific treatment was initiated and consisted of 2 weeks of intravenous penicillin followed by ceftriaxone intravenous for another 4 weeks and subsequent oral amoxicillin to complete 12 months of antibiotic therapy. For the Hodgkin's lymphoma, complete remission was documented after a total of six cycles of escalated BEACOPP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) CT and positron emission tomography (PET) before treatment including pathological mediastinal lymph nodes; (B) CT and PET after 2 months of treatment; (C) CT and PET 4 weeks after treatment of the lymphoma and after 3 months of antibiotic treatment of the pulmonary actinomycosis.
See this image and copyright information in PMC

References

    1. Eichenauer DA, Engert A, Dreyling M, et al. ; ESMO Guidelines Working Group. Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22(Suppl 6):vi55–8 - PubMed
    1. Hutchings M, Loft A, Hansen M, et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006;91:482–9 - PubMed
    1. Southwick F. Pulmonary infections, rarer causes of community-acquired pneumonia, actinomycosis. In: Southwick F, ed. Infectious diseases a clinical short course. 2nd edn McGraw-Hill Companies, 2008:99
    1. Mabeza GF, Macfarlane J. Pulmonary actinomycosis. Eur Respir J 2003;21:545–51 - PubMed
    1. Kim SR, Jung LY, Oh IJ, et al. Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients. BMC Infect Dis 2013;13:216. - PMC - PubMed

Publication types